Treace Medical Concepts (TMCI) Cash from Investing Activities Growth (3y) (2023 - 2026)
Powered by 
Analysis
Treace Medical Concepts (TMCI) Cash from Investing Activities Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 17.83% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -26.99% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -44.28% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | -6.23% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | -32.54% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -68.12% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 18.69% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 37.39% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -17.67% |
| 10 | Treace Medical Concepts | 312.82 Mn | 267.20 Mn | 35.61 Mn | 38.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.87% |
| Mar 31, 2026 | 54.03% |
| Dec 31, 2025 | 29.09% |
| Sep 30, 2025 | 51.71% |
| Jun 30, 2025 | 14.26% |
| Mar 31, 2025 | -8.54% |
| Dec 31, 2024 | 79.68% |
| Sep 30, 2024 | 101.14% |
| Jun 30, 2024 | 228.60% |
| Mar 31, 2024 | 176.65% |
| Dec 31, 2023 | 289.07% |
| Sep 30, 2023 | 333.13% |
| Jun 30, 2023 | -247.21% |
| Mar 31, 2023 | -392.43% |